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Abstract The prevalence of immune-mediated diseases, such as allergies and type 1 diabetes,
is on the rise in the developed world. In order to explore differences in the gene expression
patterns induced in utero in infants born in contrasting standards of living and hygiene, we
collected umbilical cord blood RNA samples from infants born in Finland (modern society),
Estonia (rapidly developing society) and the Republic of Karelia, Russia (poor economic
conditions). The whole blood transcriptome of Finnish and Estonian neonates differed from their
Karelian counterparts, suggesting exposure to toll-like receptor (TLR) ligands and a more
matured immune response in infants born in Karelia. These results further support the concept
of a conspicuous plasticity in the developing immune system: the environmental factors that
play a role in the susceptibility/protection towards immune-mediated diseases begin to shape
the neonatal immunity already in utero and direct the maturation in accordance with the
surrounding microbial milieu.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The prevalence of immune-mediated diseases in developed
countries is continuously increasing and is strongly corre-
lated with the standard of living. These observations have
led to the formulation of the hygiene hypothesis [1,2],
according to which environmental factors, such as microbial
and parasite infections, encountered during early childhood
suppress the development of harmful immune responses
later in life. Lack of normal microbial contacts in the
industrialized world could then predispose individuals
towards allergies and autoimmune diseases. The educationof the immune system takes place in early childhood, and at
least partly begins already during pregnancy. As an example
indicating prenatal Th2 cell priming and activity, allergen-
specific IgE antibodies can be detected at the time of birth
[3]. Environmental factors encountered in utero, such as
exposure to farms, especially stables and hay [4], and
maternal and grandmaternal smoking [5] are known to
modulate atopy and asthma in the offspring.
Estonia, Finland and Russian Karelia are adjacent areas
exposed to the same seasonal changes but differing in their
socio-economic status (Fig. 1). Finland is themostmodernized
of these societies, Estonia, since gaining independence, has
Figure 1 Map of the three study sites located in Espoo,
Finland; Tartu, Estonia; and Petrozavodsk, Russia.
138 H. Kallionpää et al.experienced a rapid economic growth, and Russian Karelia has
the poorest economic conditions of the three. In 2009, the
gestational period covered by this study, the gross domestic
product (in purchasing power parity, PPP) was 12,931 USD
in the Republic of Karelia [6] and 19,451 USD in Estonia, as
opposed to 34,720 USD in Finland [7]. This is further reflected
by the life expectancy at birth, which in 2009 was 66.6 years
in the Republic of Karelia [6], 74.3 years in Estonia, and
79.6 years in Finland [8]. Previous studies comparing Finnish
school children to their peers in Russian Karelia have shown
that the incidence of type 1 diabetes is almost six times higher
in Finland [9]. In Estonia the incidence of type 1 diabetes is
increasing and is currently more than two times higher than in
Russian Karelia, and almost three times lower than in Finland
[10,11]. The prevalence of asthma, hay-fever and allergies is
also rising in Finland, but has remained stable in Russia [12].
Conversely, compared to Finnish children, Karelian children
are more frequently exposed to microbial infections, such asTable 1 Characteristics of the umbilical cord blood RNA sample
details on the samples.
Espoo
Number of samples 48
Males/females 26/22
Average gestational week 39.3 (36–42)
HLA risk class a
HLA-DR3-DQ2 positive b
HLA-DR4-DQ8 positive c
NP: 36 samples
M: 4 samples
H: 6 samples
VH: 2 samples
8 samples
12 samples
Birth dates January–May 2010
a NP = neutral or protective genotypes, M = moderate risk associated
associated genotypes (Peet et al. [14]).
b HLA-DQA1*05-DQB1*02 haplotype.
c HLA-DRB1*04:01/2/4/5/8-DQB1*0302/4 haplotype.Toxoplasma gondii, Helicobacter pylori, as well as Hepatitis
virus A and Coxsackievirus B4, as measured by antimicrobial
antibodies [13].
In order to evaluate the influence of these contrasting
standards of living and infections, we have studied the
similarities and differences in the gene expression patterns
induced in utero in infants born in these adjacent countries.
Whole blood RNA expression profiles from umbilical cord
blood RNA samples, collected from infants born in Finland,
Estonia and Russian Karelia (Fig. 1,Table 1) were analyzed
with microarrays. Clear differences were observed in between
the study sites, with Russian Karelia deviating most clearly from
the Estonian and Finnish samples. A salient example was
observed in the expression of transcripts associated with
lipopolysaccharide (LPS) induction and sepsis, which were
higher in the samples from Karelian neonates, suggesting in
utero exposure to toll-like receptor (TLR) ligands. This provides
a strong indication, that there is an in utero influence on
susceptibility/protection towards immune-mediated dis-
eases, which begins to shape the neonatal immunity and
direct thematuration of both the adaptive and innate immune
responses in accordance with the surrounding microbial
milieu.
2. Subjects and methods
2.1. Subjects and sample collection
The samples were collected as part of the international
DIABIMMUNE study, aimed at testing the hygiene hypothesis
in the development of autoimmune and allergic diseases.
Umbilical cord blood was drawn into Tempus Blood RNA
tubes (Applied Biosystems) from children born between
January and May 2010 at the maternity unit of Jorvi Hospital
(Espoo, Finland; n = 48), maternity units of Tartu and Põlva
(Estonia; n = 25), or two maternity departments in Petroza-
vodsk (capital of the Republic of Karelia, Russian Federation;
n = 40) according to the manufacturer's protocol and then
stored at −70 °C until analyzed. All newborn infants were
full-term (N36 gestational weeks) and born vaginally
(Tables 1 and S1). The HLA-DR-DQ genotypes related tos collected at the three study sites. See Table S1 for further
Tartu Petrozavodsk
25 40
10/15 22/18
39.4 (37–42) 39.6 (37–41)
NP: 22 samples
M: 1 samples
H: 1 sample
VH: 1 sample
5 samples
2 samples
NP: 34 samples
M: 2 samples
H: 4 samples
VH: 0 samples
4 samples
7 samples
January–May 2010 January–May 2010
genotypes, H = high risk associated genotypes, VH = very high risk
Table 2 Top 15 enriched canonical pathways among the differentially regulated genes, as reported by the Ingenuity Pathway
Analysis (IPA) core analysis tool. The Genes/pathway column reports the number of differentially regulated genes in the
comparison / total number of genes annotated to the pathway. The coloring of the rows is used to highlight the overlapping
pathways observed in the three comparisons.
Espoo vs. Petrozavodsk
Ingenuity canonical pathway Genes/pathway P value
SAPK/JNK signaling 26/100 0.000447
Hypoxia signaling in the cardiovascular system 20/64 0.000724
B cell receptor signaling 38/162 0.001349
Assembly of RNA polymerase III complex 7/14 0.001349
NRF2–mediated oxidative stress response 42/187 0.001413
NGF signaling 28/111 0.001905
Cdc42 signaling 31/143 0.001905
Pyridoxal 5'–phosphate salvage pathway 19/63 0.001950
Paxillin signaling 26/110 0.002570
Integrin signaling 44/205 0.003236
Pancreatic adenocarcinoma signaling 27/115 0.003981
Growth hormone signaling 19/71 0.005012
Melanocyte development and pigmentation signaling 22/87 0.005370
FLT3 signaling in hematopoietic progenitor cells 19/73 0.008318
CD40 signaling 17/68 0.0093325
Tartu vs. Petrozavodsk
Ingenuity canonical pathway Genes/pathway P value
B cell receptor signaling 31/162 0.000001
FLT3 signaling in hematopoietic progenitor cells 16/73 0.000072
Acute myeloid leukemia signaling 16/81 0.000145
Fcγ receptor–mediated phagocytosis in macrophages and monocytes 18/95 0.000186
HMGB1 signaling 18/97 0.000214
p53 signaling 18/100 0.000417
Docosahexaenoic acid (DHA) signaling 10/41 0.000437
RAR activation 26/179 0.000646
Polyamine regulation in colon cancer 7/24 0.000933
NGF signaling 18/111 0.001096
HIF1α signaling 17/102 0.001479
IL–22 signaling 7/24 0.001660
IL–15 signaling 12/65 0.001995
Rac signaling 17/117 0.002042
AMPK signaling 20/143 0.002089
Espoo vs. Tartu
Ingenuity canonical pathway Genes/pathway P value
Granzyme A signaling 3/17 0.000191
Renal cell carcinoma signaling 4/17 0.001148
FGF signaling 4/87 0.002570
Actin cytoskeleton signaling 6/230 0.002884
SAPK/JNK signaling 4/100 0.002951
Chronic myeloid leukemia signaling 4/102 0.003467
Telomerase signaling 4/99 0.004074
NGF signaling 4/111 0.005754
ErbB2–ErbB3 signaling 3/58 0.006026
Role of NANOG in mammalian embryonic stem cell pluripotency 4/113 0.006310
Insulin receptor signaling 4/131 0.010471
Neurotrophin/TRK signaling 3/70 0.010471
GDNF family ligand–receptor interactions 3/70 0.010965
Prolactin signaling 3/77 0.013183
PDGF signaling 3/79 0.015136
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140 H. Kallionpää et al.type 1 diabetes risk were analyzed with a lanthanide
labeled oligonucleotide hybridization method as described
previously [15]. The subjects were divided into four groups
based on their HLA-associated risk for T1D [14] (Tables 1 and
S1). The study protocols were approved by the ethical
committees of the participating hospitals and the parents
gave their written informed consent.
2.2. RNA isolation
Total whole-blood RNA was extracted from the samples
using Tempus Spin RNA isolation kit (Applied Biosystems)
according to manufacturer's instructions. RNA quality and
quantity was determined using NanoDrop ND-2000 (Thermo
Scientific) and Experion Automated Electrophoresis System
(Bio-Rad Laboratories).
2.3. Array hybridizations
50 ng of total RNA was processed to cDNA with Ovation RNA
amplification system v2, including the Ovation whole blood
reagent (NuGEN Technologies). The amplified cDNA was
subsequently biotin-labeled and fragmented with Encore
biotin module (NuGEN Technologies). Samples were hybrid-
ized to whole genome GeneChip Human Genome U219 array
plates (Affymetrix) in accordance with the manufacturer's
protocols for using the GeneTitan Hybridization, Wash and
Stain Kit for 3′ IVT Array Plates (Affymetrix). A GeneTitan MC
Instrument (Affymetrix) was used to hybridize, wash, stain,
and scan the arrays. The probe cell intensity data was
summarized with Affymetrix GeneChip Command Consol 3.1.
The microarray data discussed in this publication are accessible
through GEO SuperSeries accession number GSE53473 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53473).
2.4. Microarray data processing and statistical analysis
The intensity data was pre-processed using robust multi-array
averaging (RMA) [16]. The absent call filtering was performed
by determining the threshold value empirically for each sample,
as described by [17]. A two-component Gaussian Mixture model
was fitted for the non-control probe sets of each chip with an
Expectation Maximization algorithm, which was implemented
using the mixtools-package in R [18]. The assumption is that
each component of the distribution would correspond to a
different source of signal (background and true expression). A
probe set was filtered out if it was absent in at least 50% of the
samples from Espoo, Tartu and Petrozavodsk.
As the Espoo and Tartu RNA sampleswere hybridized to array
plates in December 2011–January 2012 and the Petrozavodsk
samples in March 2013, the differences between Petrozavodsk
and the other areas were confounded by a batch effect. In order
to correct for this effect, 15 samples (seven from Petrozavodsk,
four from Espoo and four from Tartu) were re-hybridized on the
sameAffymetrix U219 platform. The batch correctionwasmade
by applying the ComBat analysis method [19], which imple-
ments an empirical Bayes framework to adjust for the batch
effect.
Differential expression was detected by using the R
Bioconductor [20] package Limma [21] to fit a linear model
and compute a moderated t-statistic for each present probeset for all three comparisons: Espoo vs. Petrozavodsk, Tartu
vs. Petrozavodsk and Espoo vs. Tartu. Gender, pregnancy
week, month of birth, and HLA risk class were included as
confounding factors in the model. A probe set was deemed
differentially expressed if its Benjamini–Hochberg-corrected
P value, estimated as the false discovery rate (FDR), was lower
than 0.01. The probe sets meeting this criteria are listed in
Table S2.2.5. Molecular pathway enrichment
Molecular pathway enrichment was tested using the Ingenuity
Pathway Analysis (Ingenuity Systems, www.ingenuity.com)
core analysis tool. The top 15 enriched canonical pathways
among the differentially regulated genes are listed in Table 2.2.6. Differentially expressed genes with functions
related to the innate immunity responses
The human genes with literature-annotated function in the
innate immunity were downloaded from www.innatedb.org
[22]. The enrichment of these genes among our differential-
ly expressed genes was calculated using Fisher's exact test
and the Benjamini–Hochberg-corrected P values are report-
ed in Table S3. Specific information on the function in innate
immunity is listed beside each gene in Table S2 (InnateDB
columns).2.7. Differentially regulated genes associated with
developmental regulation of the immune response
Two recent studies reporting transcriptomic changes in
1-year-old infants and newborn infants were selected for
comparisons with our data. Martino et al. [23] studied LPS
induction in mononuclear cells at birth and at 1 year of age.
They reported 549 genes that were differentially expressed
between these age groups. The enrichment of these genes
among our differentially expressed genes was calculated using
Fisher's exact test and the Benjamini–Hochberg-corrected P
values are reported in Table S3 and Fig. 4.
Wynn et al. [24] performed whole blood transcriptomics
upon bacterial sepsis infection in different age groups
of children relative to healthy control children. From the
associated pre-processed and normalized microarray data sets
from Gene Expression Omnibus (GSE26440 and GSE26378), data
from neonates (age b 1 month) and infants (0.5 years b age b
1.5 years) was selected. In both age groups, approximately 1/3
of these samples were from healthy controls and 2/3 were from
patients with bacterial sepsis. After fitting a linear model, a
moderated t-statistic [21] was computed for each probe set,
taking health status (sepsis/healthy) and survival as confound-
ing factors in the analysis. There were 2205 genes that were
identified as upregulated and 1432 genes downregulated in the
older infants compared to the neonates. The enrichment
of these genes among our differentially expressed genes
was calculated using Fisher's exact test. The Benjamini–
Hochberg-corrected P values are reported in Table S3 and
Fig. 4.
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3.1. Place of birth affects hundreds of genes in the
umbilical cord blood transcriptome
Using the criteria of an adjusted P value b 0.01, 3442 probe
sets were differentially regulated between Espoo and Petro-
zavodsk, 130 probe sets between Espoo and Tartu, and 1655
probe sets between Tartu and Petrozavodsk (Fig. 2, Table S2).
A majority of the differences were observed between Espoo
and Petrozavodsk. The umbilical cord blood transcriptome of
infants born in Tartu shared greater similarity with the infants
born in Espoo, than to that of infants born in Petrozavodsk.
Molecular pathway enrichment was tested by using the IPA
core analysis pathway tool (Table 2). Interestingly, the B cell
receptor signaling pathway was significantly enriched among
the differentially expressed genes in samples from Espoo and
Tartu compared to Petrozavodsk. For example, CD79B coding
for B cell antigen receptor Ig-beta protein, and PAX5 coding
for transcription factor crucial for B cell lineage commitment,
were suppressed in samples from Petrozavodsk. Differences in
the NGF and CD40 signaling pathways were mainly due to
the downregulation of MAPK signaling molecules in Espoo
and Tartu. Pathways linked to FLT3 activity (FLT3 signaling in
hematopoietic stem cells and acute myeloid leukemia
signaling) were suppressed in samples from Espoo and Tartu
relative to samples from Petrozavodsk. FLT3 is a plasma
membrane receptor expressed by hematopoietic stem and
progenitor cells in the bonemarrow, thymus and lymph nodes,Figure 2 Summary of the number of probe sets showing
differential regulation (corrected P value b 0.01, moderated
t-test) between the cord blood transcriptome of infants born in
Espoo (Finland, n = 48), Tartu (Estonia, n = 25) and Petrozavodsk
(Russian Karelia, n = 40).and is required for example for the normal proliferation and
development of dendritic cells (DC) in the periphery [25].
3.2. Common transcriptome regulation in Finnish
and Estonian children when compared to Russian
Karelia
From the comparisons with the Petrozavodsk samples, the
Espoo and Tartu infants shared four hundred seventy-five
upregulated probe sets and 424 downregulated probe sets
(Fig. 2, Table S2). As a highlight, the ZFP36 ring finger
protein-like 1 (ZFP36L1) gene was highly upregulated both in
Espoo and Tartu when compared to Petrozavodsk (2 and
1.8-fold, Fig. 3A). ZFP36L1 is a RNA binding protein involved
in a variety of mRNA processing steps that is expressed in
lymphoid and myeloid hematopoietic lineages, and inhibits
erythroid differentiation through degradation of Stat5b mRNA
[26]. ZFP36L1 has also been shown to maintain the immature
state of B cells and negatively regulate plasma cell differen-
tiation by targeting transcription factor BLIMP1 [27]. Notably,
SNPs in the proximity of this gene reside in a genetic locus
shared between many autoimmune diseases, and these SNPs
have been associated as lead SNPs with celiac disease (CD),
Crohn's disease and type 1 diabetes [28]. PTCRA was also
upregulated in children from both in Espoo and Tartu, relative
to Petrozavodsk (1.8 and 1.7-fold, Fig. 3B). PTCRA codes for
pre-T cell antigen receptor alpha, which together with T cell
receptor β forms a pre-TCR complex in immature T cells. This
receptor then facilitates the expansion and differentiation
of precursor T cells. PTCRA expression has been observed to
increase in the double negative (CD4- CD8-) stage of the αβT
cell development, and then gradually declinewhen cells reach
the single positive stage [29].
3.3. Differentially regulated genes associated with
innate immune responses
Newborn infants are mostly dependent on their innate
immunity to fight against pathogens. In order to test whether
the detected expression differences were related to the
functions of the innate immune system, the differentially
regulated genes were compared against the InnateDB [22].
Genes of the innate immune system were enriched in
the upregulated genes in Petrozavodsk, when compared
to Espoo and/or Tartu, and in the downregulated genes in
Petrozavodsk, when compared to Espoo (Table S2, Innate
Immunity columns, and Table S3). The innate immunity genes
upregulated in Petrozavodsk relative to Espoo and/or Tartu
included several pattern recognition receptors responsible
for microbial sensing, such as Toll-like receptor 2 (TLR2,
1.3-fold when compared to Espoo), an essential receptor
in the defense against Gram-negative bacteria by the mono-
cytes and macrophages, as well as absent in melanoma 2
(AIM2, 1.5 and 1.8-fold) that codes for the central cytosolic
double-stranded DNA sensor of bacteria and DNA viruses [30]. In
addition, Nod-like receptors C4 and C5 (NLRC4, NLRC5) were
upregulated in Petrozavodsk when compared to Espoo (both
1.3-fold).
Complement component 4 binding protein alpha (C4BPA)
was among the most highly upregulated genes in Petrozavodsk
when compared to Espoo (2.4-fold) and Tartu (2.3-fold).
Figure 3 Example box plots of genes showing differential regulation in Petrozavodsk compared to Espoo and Tartu. (A) ZFP36L1
coding for ZFP36 ring finger protein-like 1, (B) PTCRA coding for pre-T cell receptor alpha, (C) GPR34 coding for G-protein coupled
receptor 34, and, and (D) ATG5 coding for autophagy related 5. Dark horizontal line represents the median, with the box representing
the 25% and 75% percentiles. The whiskers extend to the most extreme data point which is no more than 1.5 times the interquartile
range from the box. The outliers are presented as open circles. **FDR b .01, ***FDR b .001 (moderated t-test).
142 H. Kallionpää et al.Together with C4BPB (beta isoform) it can form the C4BP
complex (withα7β1,α6β1, and α7β0 compositions) and act as
the major inhibitor of the classical and lectin complement
pathways. Additionally, it has been observed to activate B-cell
proliferation and IgE production through binding to CD40 [31],
and more recently the α7β0 isoform was shown to induce
a tolerogenic, anti-inflammatory state in DCs [32]. Another
complement inhibitor CD46 (also known as membrane cofac-
tor protein, MCP) was also upregulated in the samples from
Petrozavodsk (1.4-fold in both comparisons). This transmem-
brane protein is ubiquitously expressed to protect autologous
cells from complement activation by binding to C3b and
C4b complement proteins and promoting their degradation.
Similarly to C4BPA, CD46 has diverse functions beyond the
complement system: CD46 activation has been reported to be
crucial for type 1 interferon production in macrophages [33].
CD46 also promotes T regulatory cell (Treg) induction towards
the IL-10 secreting anti-inflammatory Type 1 Treg (Tr1) subset
[34], and even from polarized T helper type 1 (Th1) cells [35].
In addition to C3b and C4b complement proteins, CD46 also
binds to Jagged1, which prevents the interaction of Notch1and Jagged1 in resting T cells and prevents IFNγ production
[36].3.4. Differentially regulated genes associated with
developmental regulation of the immune response
With a view to establish whether these contrasting expression
levels were related to differences in the developmental or
maturation status of the neonatal immune system between
the study sites, we compared our observationswith two recent
studies that reported transcriptomic changes occurring in
monocytes by LPS induction at birth and at 1 year of age [23]
and in whole blood upon bacterial sepsis infection between
different age groups of children relative to healthy control
children [24]. Both studies reported profound differences in
neonatal responses compared to the other age group(s). The
analyses revealed that genes upregulated in Petrozavodsk
(downregulated in Tartu and/or Espoo) had a significant
overlap with the LPS induced genes upregulated at 1 year of
age compared to newborn infants (Table S3). From our
143Standard of hygiene and immune adaptation in newborn infantsre-analysis of the public of the sepsis study [24], we identified
genes that were up- and downregulated between neonates
and 1-year-old children. In similarity to the LPS dataset, genes
upregulated in Petrozavodsk (downregulated in Tartu and/or
Espoo) had a significant overlap with genes upregulated in
sepsis at 1 year of age (Table S3). Genes upregulated in Espoo
and/or Tartu relative to Petrozavodsk were found to overlap
with the upregulated genes associatedwith sepsis in neonates.
P values for the enrichment for developmentally regulated
immune system transcripts are represented in Fig. 4.
One of the genes upregulated in Petrozavodsk, with
LPS at 1 year of age, and in 1-year-old sepsis patients was
prolylcarboxypeptidase (PRCP, 1.2-fold compared to Espoo).
PRCP encodes for a plasma membrane enzyme responsible
for activation of kallikrein that subsequently leads to the
production of vasodilator bradykinin (BK), both of which are
components of the so called plasma contact system. PRCP
expression and bradykinin production have been observed to
be induced by LPS stimulation [37] and the contact system has
recently been identified as one arm of the innate immune
system due to its activities in inhibiting bacterial growth [38].
G-protein coupled receptor 34 (GPR34) was among the genes
upregulated in newborn infants from Petrozavodsk and with
LPS at 1 year of age (1.8 and 1.5-fold when compared to Espoo
and Tartu, Fig. 3C). GPR34 is highly expressed on mast cells
and less abundantly also in other immune cell types [39]. TheFigure 4 Developmental regulation of the immune response in
Hochberg corrected P values for enrichment (Fisher's exact test)
regulated by (A) LPS in mononuclear cells isolated from newborn in
blood of newborn infants or 1 year-old infants [24] are presented. En
upper panel, and with newborn-specific genes on the lower pane
downregulated genes. The cutoff for enrichment significance (P = 0
further details on the overlapping genes and P values.functional significance of this receptor remains unclear, but it
was recently associated with controlling T-cell responses and
pathogen clearance, as knockout mice exhibited increased
paw swelling in the delayed type hypersensitivity test and
were also more susceptible to the fungal pathogen
Cryptococcus neoformans. Among the genes associated with
sepsis at 1 year of age and upregulated in Petrozavodsk,
autophagy related 5 (ATG5, 1.3 and 1.2-fold, Fig. 3D) has been
widely connected to immune functions, such as recognition of
single-stranded RNA viruses and type 1 interferon production
in DCs [40], antigen presentation on DCs and subsequent CD4+
T-cell priming [41], as well as to immune mediated diseases,
such as multiple sclerosis [42] and asthma [43].4. Discussion
This study has investigated the influence of the environ-
ment, modern vs. traditional differing in the incidence of
both infectious and immune-mediated diseases, on the cord
blood transcriptome at birth. Although no major differences
were detected between samples from Espoo (modern
society) and Tartu (rapidly developing society), samples from
Petrozavodsk (traditional society) differed from the samples
taken from infants born in other study sites, and especially
from Espoo. Upregulation of several pivotal innate immunecord blood in the three study sites. Logarithmic Benjamini–
of the differentially regulated genes with genes differentially
fants or 1-year-old infants [23] or (B) bacterial sepsis in whole
richment overlap with infant-specific genes is presented on the
l. The red bars correspond to upregulated and blue bars to
.01) is presented with dashed horizontal lines. See Table S3 for
144 H. Kallionpää et al.response mediators, such as TLR2, AIM2, ATG5, and IRF7 in
samples from Petrozavodsk was evident. Interestingly, TLR2
has been reported to be upregulated in mononuclear cells at
birth upon infection with Gram-positive bacteria [44], and
conversely downregulated in cord blood CD34+ progenitor
cells of infants at high-atopic risk [45]. IRF7 on the other hand
plays a central role in the viral defense and in the induction of
the interferon response [46], and shows genetic association
with susceptibility to type 1 diabetes [47]. It has also been
suggested that the innate immune responses play a role in the
development of allergy. For example, a multinational study
demonstrated an association between maternal contact with
farm animals during pregnancy, higher expression of CD14
and toll-like receptors 1 to 9, and a protective effect on the
development of atopic dermatitis in the first 2 years of life
[48]. Therefore, the detected activation of innate immunity
genes in Petrozavodsk newborn infants, which is usually
associated with subsequent Th1 responses, might confer later
protection from aberrant Th2 responses, associated with atopy
and asthma.
Notably, genes that were upregulated in samples from
Petrozavodsk relative to those from either Espoo or Tartu
overlapped with genes previously identified to be induced by
LPS in mononuclear cells at 1 year of age, but not at birth. The
upregulated signature in samples from Petrozavodsk also
overlapped with that of 1-year-old children with bacterial
sepsis (Fig. 4). Altogether this suggests that the infants born in
Petrozavodsk have been exposed to TLR ligands in utero, and
that the subsequent immune response is developmentally more
advanced, resembling that of matured infants. In support of
this, it was recently reported that neonatal antigen presenting
cells (APC) from Papua New Guinean (traditional environment)
had a more activated and mature baseline status than APCs
from Australian (modern environment) neonates, as deter-
mined by increased expression of activation markers HLA-DR
and CD86, but that the APCs from Papua New Guinea were also
more quiescent and resistant to further LPS stimulation [49].
This supports the implication that the surrounding bacterial
environment is preprogramming the immune responses in
utero, and that this environment would differ in Petrozavodsk
versus the other study sites. In fact, data on house dust sample
analysis in Finnish and Russian Karelian homes revealed striking
differences, as both the amount of bacterial content and
diversity were higher in Russian Karelia than in Finland [50].
Lisciandro et al. [49] suggested that the differences in the state
of activation of antigen presenting cells fromneonates between
modern and traditional environments reflect an evolutionary
mechanism of immune regulation learned in utero to prepare
newborn infants for the intensity and frequency of the immuno-
logical challenges in the postnatal environment and to protect
them from infections.
Markers associated with immature immune cell phenotypes,
such as ZFP36L1 inhibiting plasma cell and erythroid differen-
tiation, and pre-T cell receptor alpha (PTCRA) expressed in
immature T cells, were upregulated in newborn infants from
Espoo and Tartu (Figs. 3A–B). ZFP36L1 downregulation, similar
to that seen in samples from Petrozavodsk, has been observed
in murine B cells after LPS stimulation and during the shift from
mature B cell to plasma cell [27]. This suggests that not only
innate immune cells, but also adaptive T and B cells in newborn
infants from Espoo and Tartu have a more immature phenotype
and have not been activated and/or differentiated to theextent observed in Petrozavodsk infants. On the other hand, it
also appeared that inhibitory or homeostasis mechanisms
were activated in Petrozavodsk, such as CD46 with a role
of suppressing Th1 responses in infection [36]. CD46-induced
Tregs have been hypothesized to ensure unresponsiveness to
commensal bacteria while maintaining defense against invad-
ing pathogens by allowing DC maturation [51]. Interestingly,
CD46 responsiveness is defective in T cells from patients
with multiple sclerosis [52], asthma [53] and juvenile and
rheumatoid arthritis [35]. In this respect, upregulation of
the multifunctional C4BPA in Petrozavodsk was an interesting
finding. This protein has immunomodulatory downstream
effects on DCs, as was demonstrated when treatment of DCs
with LPS and C4BPA promoted Treg differentiation instead of
inducing activation markers and Th1 programming [32]. It
is intriguing to speculate, that such a tolerant state of the
APCs and lymphocytes induced in uterowould lead to different
immune responses upon colonization with the commensal
flora or infections after birth, and that a similar protective
shift in the prenatal host-microbe interaction might be
achieved by probiotics in the modern environments [54].
As this study was performed using umbilical cord whole
blood samples consisting of heterogeneous cell populations,
it was not possible to identify which cell types were
responsible for the detected differences. This warrants
further investigation and validation, for example the
frequency of different cell populations needs to be analyzed
more carefully. In addition, a number of differentially
expressed cell surface proteins, such as CD46 and FLT3,
could be quantified simultaneously. An unavoidable limitation
of this study was the collection of samples at three different
study sites, although possible batch effects were kept at
minimum by stabilizing the RNA immediately after the blood
draw into the preservative buffer present in the collection
tubes, as well as storing the samples at −70 °C until
processing and analysis in the same laboratory. Any batch
effects related to hybridization were eliminated during the
data analysis as well as possible. In the light of the differences
observed within these data, repetition and validation of the
study in another cohort of neonates born in contrasting
standards of living should strengthen this hypothesis. More-
over, the influence of maternal diet, microbiome, infections,
and the course of pregnancy and child birth would certainly be
of interest for future investigations. Additionally, genetic
differences between the populations could partly explain the
results, and therefore the T1D-related HLA risk class was
regarded as one of the confounding factors in the analysis.
However, based on the genome-wide SNP genotyping, Estonians
and Russians are rather similar to each other, differing clearly
from the Finns [55]. Therefore, the genetic factors are an
unlikely explanation for the similarities detected here between
Finland and Estonia, or for the dissimilarities detected between
Estonia and Russia.
In summary, we report here the first whole-genome
transcriptomic study describing the differences in immunolog-
ically active genes in the umbilical cord whole blood samples
from neonates born in contrasting standards of hygiene and
living. The findings support the hygiene hypothesis, but at
the same time extend the immunomodulatory window to the
prenatal period. The environmental factors that play a role in
the susceptibility/protection towards immune-mediated dis-
eases begin to shape the neonatal immunity already in utero
145Standard of hygiene and immune adaptation in newborn infantsand direct the maturation of both the adaptive and the innate
immune responses in accordance with the surrounding micro-
bial milieu. This could then have far reaching effects on
immune functions later in childhood, and dictate the outcome
of the balance between efficient immune responses against
pathogens and development of immune mediated diseases.
Supplementary data to this article can be found online at
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